{
    "answer": "Cosentyx's net sales in the immunology segment for the full year 2024 were $50.3 billion (reported), and $50.3 billion (constant currency). These results were a 10% growth from Cosentyx's immunology segment sales of $5.0 billion (reported) and $5.0 billion (constant currency) in the corresponding 2023 period, with no growth in terminally influenced defined benefits categories.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 5,
    "search count": 4,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        923,
        2785,
        4429,
        6328,
        8153
    ]
}